Literature DB >> 7913748

Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene.

B D'souza1, J Taylor-Papadimitriou.   

Abstract

Overexpression of the ERBB2 receptor in transfectants of a human mammary epithelial cell line (MTSV1-7) is associated with a reduced ability to undergo morphogenesis in vitro and with a decreased level of expression of the E-cadherin and alpha 2 integrin genes. The inhibition of expression of the adhesion molecules has been shown to be at the level of transcription by using nuclear run-on assays and by following transcription of a reporter gene fused to 5' sequences of the E-cadherin gene. To relate the effects on gene transcription to a functional ERBB2 protein, signaling from the receptor was inhibited by the antibody 4D5, which blocks phosphorylation of ERBB2 on tyrosine residues and association of the protein with the GRB2/Sem5 protein. After treatment with the antibody 4D5, the ERBB2 transfectants regain the ability to form three-dimensional structures in collagen gels and the rates of transcription of the genes encoding the E-cadherin and the alpha 2 integrin subunit are restored to the levels seen in MTSV1-7neo cells. These results demonstrate that the inhibition of morphogenesis and transcription of specific adhesion molecules in human mammary epithelial cells can be affected by signals generated by the ERBB2 receptor and suggest a role for ERBB2 overexpression in tumor progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913748      PMCID: PMC44367          DOI: 10.1073/pnas.91.15.7202

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  C Puissant; L M Houdebine
Journal:  Biotechniques       Date:  1990-02       Impact factor: 1.993

2.  Plasmid vectors with multiple cloning sites and cat-reporter gene for promoter cloning and analysis in animal cells.

Authors:  T Frebourg; O Brison
Journal:  Gene       Date:  1988-05-30       Impact factor: 3.688

3.  Localization of specificity determining sites in cadherin cell adhesion molecules.

Authors:  A Nose; K Tsuji; M Takeichi
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

4.  Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock.

Authors:  C R King; I Borrello; L Porter; P Comoglio; J Schlessinger
Journal:  Oncogene       Date:  1989-01       Impact factor: 9.867

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

7.  p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.

Authors:  R M Hudziak; G D Lewis; M Winget; B M Fendly; H M Shepard; A Ullrich
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

8.  Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.

Authors:  L Buday; J Downward
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

10.  A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.

Authors:  K Semba; N Kamata; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  37 in total

Review 1.  Progesterone signaling and mammary gland morphogenesis.

Authors:  G Shyamala
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

2.  Cell adhesion molecules.

Authors:  A J Freemont; J A Hoyland
Journal:  Clin Mol Pathol       Date:  1996-12

3.  Neuregulin-mediated ErbB3 signaling is required for formation of zebrafish dorsal root ganglion neurons.

Authors:  Yasuko Honjo; Jonathan Kniss; Judith S Eisen
Journal:  Development       Date:  2008-07-03       Impact factor: 6.868

Review 4.  Modulation of epithelial cell adhesion in gastrointestinal homeostasis.

Authors:  J A Efstathiou; M Pignatelli
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 5.  Demystified ... adhesion molecules.

Authors:  A J Freemont
Journal:  Mol Pathol       Date:  1998-08

Review 6.  Phosphotyrosine isosteres: past, present and future.

Authors:  Robert A Cerulli; Joshua A Kritzer
Journal:  Org Biomol Chem       Date:  2019-11-28       Impact factor: 3.876

Review 7.  The cadherin-catenin superfamily in endocrine tumors.

Authors:  S Semba; M Yamakawa; H Sasano
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

8.  Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.

Authors:  K Yoshiura; Y Kanai; A Ochiai; Y Shimoyama; T Sugimura; S Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Expression of e-cadherin in high-risk breast cancer.

Authors:  Eugene M Howard; Stephen K Lau; Robert H Lyles; George G Birdsong; Jay N Umbreit; Ruby Kochhar
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-01       Impact factor: 4.553

Review 10.  The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.

Authors:  Hisataka Sabe; Shigeru Hashimoto; Masaki Morishige; Eiji Ogawa; Ari Hashimoto; Jin-Min Nam; Koichi Miura; Hajime Yano; Yasuhito Onodera
Journal:  Traffic       Date:  2009-04-21       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.